Therapeutic Plasma Exchange in MG

Completed

Conditions studied: Myasthenia Gravis

In brief

The primary objective of the study is to longitudinally profile immunoglobulin levels and autoantibody levels in subjects with myasthenia gravis (MG) who receive therapeutic plasma exchange (TPE).

Key facts

Study ID
NCT01927692
Run by
Duke University
People needed
11
Starts
2013-07-01
Expected to finish
2014-10-01
Last updated by the study team
2015-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.